Standex International Corporation (SXI) Income Statement

The sequence of year-over-year growth rates, moving from negative territory in late 2024 and early 2025 to consistent positive readings through 2026 and into 2027 Q1, points to a recovery rather than a single-quarter anomaly. However, the magnitude of recent growth remains modest and the reported figures do not disaggregate volume, pricing, or acquisition contribution, so the durability of the rebound cannot be confirmed from the income statement alone. Investors should monitor whether growth holds above mid-single digits in subsequent quarters.

The gross margin trajectory suggests improved pricing discipline or mix benefits over the last several quarters, with the 2026 Q4 reading of 46.5% representing the high point in the series. Margins have not yet shown a consistent upward trend, as 2026 Q2 and Q3 both fell back to roughly 39%, which points to some cyclicality in the cost base or product mix. Relative to peers such as Curtiss-Wright at 37.2%, SXI appears competitive, though the reported data does not reveal whether this reflects structural pricing power or temporary favorable conditions.

Gross profit has grown more steadily than operating income over the period, and SG&A has fluctuated between roughly $40M and $68M per quarter, which makes it hard to attribute operating income changes to overhead efficiency alone. The 2026 Q4 spike in operating margin to 38.5% coincides with a rise in SG&A to $52.5M from a higher level in 2025 Q4, which suggests the swing may reflect one-time or timing effects rather than structural leverage. Operating leverage cannot be confidently concluded from the available quarterly figures.